<DOC>
	<DOCNO>NCT02304913</DOCNO>
	<brief_summary>This randomize controlled trial aim investigate hypoglossal acupuncture comparison sham acupuncture standard medical treatment ( dietary recommendation ) treatment dysgeusia cancer patient undergo chemotherapy .</brief_summary>
	<brief_title>Hypoglossal Acupuncture Dysgeusia Patients Undergoing Chemotherapy</brief_title>
	<detailed_description>Taste disorder frequent side effect patient undergo chemotherapy ( CTX ) . Dysguesia prevalence rate 16 % 1000 % CTX sometimes also persistent course . Impact dysguesia appetite , body weight well health-related quality life show . Until , evidence adequate treatment option limit specific diary recommendation . Acupuncture treatment side effect chemotherapy investigate nausea xerostomia , dysguesia . Therefore , randomize control trial aim investigate hypoglossal acupuncture comparison sham acupuncture standard medical treatment ( dietary recommendation ) treatment dysgeusia cancer patient undergo chemotherapy .</detailed_description>
	<mesh_term>Dysgeusia</mesh_term>
	<mesh_term>Taste Disorders</mesh_term>
	<criteria>Initial treatment platinumcontaining taxanebased CTX ( regardless length CTX cycle ) Breast cancer Phantogeusia ( average â‰¥4 NRS ) Willingness participate study write informed consent Severe stomatitis Dysgeusia CTX base neurological disease ingestion drug taste disorder side effect Leucopenia/neutropenia Intake anticoagulant Smoking Severe physical mental comorbidity ( due patient unable participate study ) Participation CAM treatment within integrative oncology care Participation study effectiveness intervention oral complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>